atai Life Sciences (ATAI) Misses Q2 EPS by 20c

atai Life Sciences (NASDAQ: ATAI) reported Q2 EPS of ($0.36), $0.20 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $270 thousand.

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• Honda Motor names Mamadou Diallo as Auto Business Center EVP
• Western Digital (WDC) call put ratio 1.1 calls to 1 put as share price up 4.2%